Organovo (ONVO) Tops Q2 EPS by 1c
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Organovo (NASDAQ: ONVO) reported Q2 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.38 million.
Fiscal-Year 2017 Outlook
The Company affirmed its full-year fiscal 2017 outlook for total revenue and net cash utilization. The Company continues to expect:
|Fiscal-Year 2017 Outlook (October 2016)||Fiscal-Year 2017 Outlook (November 2016)|
|Fiscal-Year 2017Total Revenue||$4.5 million - $6.2 million||Affirmed|
|Net Cash Utilization||$31.0 million - $34.0 million||Affirmed|
For earnings history and earnings-related data on Organovo (ONVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- SeaChange Int'l (SEAC) Tops Q3 EPS by 2c; Guides Q4, FY17 Below Views
- Applied DNA Sciences (APDN) Misses Q4 EPS by 1c